01—Abstract
Summary
Summary of the 8-K filed December 1, 2025. Cited figures are marked; the original filing is the authoritative source.
Thermo Fisher Scientific Inc. (TMO) announced the issuance of €1.0 billion in Floating Rate Senior Notes due 2027 and €1.1 billion in 3.628%a Senior Notes due 2035 by its indirect wholly-owned finance subsidiary, Thermo Fisher Scientific (Finance I) B.V.
The Company is fully and unconditionally guaranteeing these notes on a senior unsecured basis. This transaction represents a significant capital raise totaling approximately €2.1 billion in net proceeds after expenses. The proceeds from this offering are intended for general corporate purposes, including potential acquisitions, debt repayment, working capital needs, capital expenditures, or equity repurchases.
The company may also temporarily invest these proceeds in short-term liquid investments. The issuance of these notes provides Thermo Fisher with substantial financial flexibility for strategic initiatives and operational needs.
02—Key points
Key Highlights
- Thermo Fisher Scientific (Finance I) B.V. issued €1 billion in Floating Rate Senior Notes due 2027 and €1.1 billion in 3.628% Senior Notes due 2035.
- The Company has provided a full and unconditional senior unsecured guarantee for these Notes.
- The total aggregate principal amount of the Notes issued is €2.1 billion.
- Net proceeds from the offering are estimated to be approximately €2.09 billion after deducting expenses.
- Proceeds are earmarked for general corporate purposes, including potential acquisitions, debt refinancing, working capital, capital expenditures, or share repurchases.
- The Fixed Rate Notes have a redemption feature allowing for early redemption under specific conditions, including a 'Par Call Date' and potential change of control events.
- The Notes are unsecured obligations and rank equally with existing and future unsecured, unsubordinated debt of the issuer and guarantor.
03—Questions
Frequently Asked Questions
What is the purpose of this debt issuance?
The net proceeds from the sale of these notes are intended for general corporate purposes. This may include funding acquisitions, repaying or refinancing existing debt, supporting working capital requirements, financing capital expenditures, or repurchasing the Company's outstanding equity securities. The proceeds may also be temporarily invested in short-term liquid investments.
What is the total amount of new debt being issued and guaranteed?
Thermo Fisher Scientific (Finance I) B.V. is issuing €1,000,000,000 in Floating Rate Senior Notes due 2027 and €1,100,000,000 in 3.628% Senior Notes due 2035, for a total aggregate principal amount of €2,100,000,000. Thermo Fisher Scientific Inc. is providing a full and unconditional senior unsecured guarantee for these notes.
What are the terms of the new notes regarding maturity and interest?
The Floating Rate Notes mature on December 1, 2027, with interest paid quarterly. The 3.628% Fixed Rate Notes mature on December 1, 2035, with interest paid annually. Specific interest payment dates are detailed in the filing.
Are there any provisions for early redemption or repurchase of these notes?
Yes, the Fixed Rate Notes can be redeemed by the issuer prior to the 'Par Call Date' under specific conditions, based on a calculation involving present values and a Comparable Bond Rate plus 15 basis points. On or after the Par Call Date, redemption occurs at 100% of the principal amount. Additionally, upon a change of control event combined with a downgrade in the Notes' rating, the issuer may be required to offer to repurchase the notes at 101% of the principal amount.
04—Continue